You are here:

Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood conditions

Blood conditions Products

A list of all our products on blood conditions

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceHealth technology evaluationHealthTech guidanceHighly specialised technologies guidanceMedical technologies guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Apadamtase alfa for treating congenital thrombotic thrombocytopenic purpura caused by ADAMTS-13 deficiency [ID6192]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
18 February 2026
Expected publication date:
TBC